Healthcare and life sciences in Germany

Clifford Chance

Clifford Chance multidisciplinary global life sciences, healthcare & chemicals team, led by Peter Dieners and Ulrich Reese, is among the top addresses in Germany and offers comprehensive advice to its clients. The practice covers current developments in the healthcare sector, such as the use of AI, the increasing use and approval of digital healthcare apps including related data protection and reimbursement law matters, as well as topics pertaining to medical robotics, the development of fully integrated digital healthcare platforms and cyber attacks. Also active in the ever-growing healthcare technology area is Gunnar Sachs. The latter, Reese and Jörg Rhiel also assist with transactions, while Dieners is a key contact for compliance issues.

Practice head(s):

Peter Dieners; Ulrich Reese

Other key lawyers:

Gunnar Sachs; Torsten Syrbe; Jörg Rhiel; Claudia Nawroth; Carolin Kemmner; Caroline Giesen; Yannick Frost


‘Covering almost all areas, experts for many different issues – everything from a single source.’

‘Good accessibility, high quality of advice.’

‘Gunnar Sachs is a very good lawyer in healthcare law and competition law.’

‘Excellent business understanding, accessibility, active thinking, industry knowledge, best level of advice.’

‘Dr. Gunnar Sachs: Accessibility as a partner, quick response, deep knowledge of the industry, absolute understanding of business interests, understanding of projects and active thinking, friendliness, likeable person.’

Work highlights

Hogan Lovells International LLP

Hogan Lovells International LLP is among the top players in the healthcare and life sciences sector and comprehensively advises on various topics with a focus on regulatory and contractual advice pertaining to future technologies in the life sciences sector, such as novel therapies and cell therapies – Jörg Schickert (co-head of the European regulatory team), Ina Brock (product liability), Arne Thiermann (regulatory, compliance) and Matthias Schweiger (litigation) frequently take the lead here. The team also covers issues at the interfaces with public law and contract law as well as IP, IT, data protection and product liability, thus advising on digital healthcare as well as strategic cooperations between pharmaceutical and IT companies. Schickert and Brock jointly head the practice with Andreas von Falck, who focuses on life sciences as well as the chemical and high-tech industries and represents clients in patent disputes, and Tanja Eisenblätter, who is particularly well versed in medical device and pharmaceutical advertising law. Lutz Angerer regularly advises large pharmaceutical companies and private equity houses on licensing and M&A transactions.

Practice head(s):

Jörg Schickert; Tanja Eisenblätter; Andreas von Falck; Lutz Angerer; Ina Brock

Other key lawyers:

Arne Thiermann; Miriam Gundt; Matthias Schweiger


‘The team responds very quickly to inquiries. This means that smaller consultations in particular are carried out very promptly and quickly, which is extremely helpful and pleasant in everyday working life. The team’s specialist knowledge and expertise is convincing.’

‘Jörg Schickert is an outstanding lawyer who thoroughly analyzes problems in a very structured manner and quickly offers a suitable and practical solution.’

‘Arne Thiermann: I enjoy working with him. He is extremely reliable and quick and responsive to client needs.’

Key clients


Bundesverband Herzkranke Kinder e.V. (BVHK)



Chiesi Farmaceutici S.p.A.

Eli Lilly

Mirati Therapeutics


Roche Diagnostics

Work highlights

  • Advising Amylyx on market entry in Germany; Advice on pharmaceutical and pharmaceutical advertising law, the development of distribution systems, regulatory issues and the preparation of contracts.

  • Advising Roche Diagnostics in the area of ​​digital healthcare, including on data protection and regulatory aspects.

  • Advising numerous clients on criminal law issues, particularly in the area of ​​advertising law and product liability matters, such as product recalls.

Baker McKenzie

Baker McKenzie‘s advice comprehensively covers all healthcare and life sciences matters. The team is particularly well versed in regulatory and pharmaceutical law, here, practice head Thilo Räpple is a key contact; typical instructions pertain to regulatory compliance as well as physician, hospital, pharmacy and food law or pharmaceutical advertising law and social security matters. The pharmaceutical and healthcare technology industries are also increasingly advised on in the context of telemedical projects, while licensing matters are another growth area. Räpple is supported by Martin Altschwager (European and German pharmaceutical and medical device law, compliance, competition law issues in connection with healthcare products and services).

Practice head(s):

Thilo Räpple

Other key lawyers:

Martin Altschwager; Frank Pflüger; Marc Gabriel


‘An incredibly high level of expertise and yet a focus on the essentials! It doesn’t get any better.’

‘The team is very consistent on a global level in terms of quality.’

‘Frank Pflueger is a responsive and extremely competent contact, who also handles the global coordination of all inquiries cost-effectively.’

Key clients

Hexal AG

Work highlights

  • Advising international pharmaceutical companies and leading pharmaceutical industry associations on security of supply in pharmaceutical discount agreements and the privileging of EU production sites.

  • Advising and representing international and German pharmaceutical companies in defending against contractual penalty and damages claims from statutory health insurance companies due to delivery failures when implementing drug discount contracts with disputed amounts totaling several million euros.

  • Advising global pharmaceutical companies and leading pharmaceutical industry associations in the context of several projects that were at the interface with various legislative proposals at the federal level and found their way into federal politics.


CMS assists medical device manufacturers, biotechnology companies, food and cosmetics manufacturers, start-ups, service companies, hospitals and pharmacies as well as players in the research-based pharmaceutical industry. The dirverse client roster benefits from cross-practice cooperation. The practice advises on regulatory and licensing matters – including recent cooperations between manufacturers of pharmaceuticals and medical devices – as well as on medicinal cannabis, transactions and digital healthcare topics, including related data protection issues. This is complemented by capacities in contentious topics under competition and pharmaceutical advertising law. Jens Wagner (pharmaceuticals, biotechnology, medical devices and dietary supplements as well as IP) heads the team from Hamburg.

Practice head(s):

Jens Wagner

Other key lawyers:

Jörn Witt; Roland Wiring; Matthias Eck; Heike Blank


‘CMS advises us at various locations and in numerous legal areas and is one of our most important external legal advisors.’

‘What we particularly appreciate about CMS is the pragmatic and practice-oriented approach, the service orientation, the very high professional quality and the distinctive industry expertise.’

‘The Life Sciences team in Hamburg with Jens Wagner as lead partner is our central contact for all questions and topics relating to medical devices.’

Key clients

Bayer AG

Bloomwell Group

Boehringer Ingelheim Pharma

Corteva Agriscience

Eli Lilly and Company

GE Healthcare

Johnson & Johnson




Work highlights

  • Advising GE Healthcare on the AMNOG benefit assessment following the new approval of a drug, and representing it in landmark proceedings before the Federal Social Court.

  • Regulatory, contractual and compliance advice to the Bloomwell Group on structuring the business model for the telemedicine, wholesale and online mail order branches for medicinal cannabis.

  • Advising and representing PharmaEssentia Corporation in a dispute arising from a license agreement with an Austrian pharmaceutical company.

Covington & Burling LLP

Covington & Burling LLP's life sciences team is based in Frankfurt and led by pharmaceutical and medical device law specialist Adem Koyuncu, who is dually qualified as physician and lawyer. The team offers a cross-location approach and regularly advises start-ups as well as leading national and international companies in the pharmaceutical, biotechnology, diagnostics, medical technology, cosmetics and food industries. Among the key topics are transactions and internal investigations as well as regulatory matters, including pharmaceutical and medical device law, and compliance. The group frequently cooperates with the Brussels location on European issues, such as EU medical device law; interfacing data protection matters are also covered.

Practice head(s):

Adem Koyuncu


‘Adem Koyuncu’s qualifications as both a lawyer and a doctor enable a specialist discussion on a spectrum that is second to none. In discussions with medical key opinion leaders, his qualifications as a doctor and as a member of an ethics committee mean that he has a completely different level of acceptance than is usually the case. This also means he can explain legal aspects much better to doctors.’

Key clients

BioNTech SE

JenaValve Technology GmbH


EFPIA – Verband

MedTech Europe & EFPIA

Work highlights

  • Ongoing advice to the EFPIA association on various pharmaceutical law and data protection issues as well as on legal and strategic questions regarding GDPR implementation.

  • Advising a US manufacturer of medical devices on numerous clinical studies, data protection and regulatory matters, as well as on the introduction of an app and cloud-based services; also advice on medicinal advertising and medical device law.

  • Advising the European medical device association MedTech Europe and the pharmaceutical association EFPIA on the draft regulation on the European Health Data Space (EHDS).

D+B Rechtsanwälte Partnerschaft mbB

Boutique D+B Rechtsanwälte Partnerschaft mbB comprehensively advises on healthcare matters and focuses on statutory health insurance. The diverse client roster includes pharmaceutical and medical technology companies, pharmacies, physicians, hospitals, authorities and federal ministries. The firm fields a pharmaceuticals and pharmacy team led by Ulrich Grau and Constanze Püschel, a physician contract law group led by Martin Stellpflug and Thomas Willaschek and a hospital team headed by Thomas Bohle and Christian Reuther, thereby advising clients across practices, including the support in regulatory matters and interfacing data protection, advertising and criminal law issues. Digital healthcare is a recent growth area, which is also supported with a cross-practice approach, a key contact here is Christian Pinnow (in addition to physician contract and psychotherapist legislation as well as medical care centers). Jan Moeck (physician contract law and psychotherapist legislation) and Tobias Volkwein (pharmaceutical law, medical device law, statutory health insurance) are also part of the core team.

Practice head(s):

Ulrich Grau; Thomas Bohle; Martin Stellpflug; Constanze Püschel; Thomas Willaschek; Christian Reuther; Jan Moeck; Christian Pinnow; Tobias Volkwein

Other key lawyers:

Christina Deckers


‘D+B focuses on service providers and can pool its resources in this segment. This benefits the clients through competence and up-to-dateness.’

‘Thomas Bohle has a high level of professional expertise and can explain even complex issues to his clients in a comprehensible manner. We particularly appreciate his realistic assessment of the facts and prospects of legal disputes. We have been successful with him in each of our cases so far.’

‘D+B is characterized by outstanding expertise in the entire area of ​​medical law. What is particularly pleasant is the close integration of the various legal areas (including pharmaceutical, medical device, pharmacy, contract doctor and hospital law). This means that even complex legal questions get answered quickly and comprehensively.’

‘I recommend the team around Dr. Thomas Willaschek, which is characterized by its excellent technical skills as well as a very dynamic and service-oriented approach.’

‘What is worth mentioning and particularly pleasing from a client perspective is the focus, among others, of Thomas Willaschek in the area of ​​digital health, which is constantly being further developed.’

‘Unique expertise in questions relating to healthcare and excellent contacts to decision-makers in politics and self-administration.’

‘Ulrich Grau: Comprehensive expertise in all important areas of the healthcare system. Excellent individual assessments and a high success rate in all disputes are a trademark of the entire firm, but especially of Dr. Gray.’

‘Dr. Constanze Püschel: Fast response times, good availability, high level of professional expertise.’

Work highlights

  • Advising Helios Health GmbH in the regulatory area on innovative digital health projects.

  • Regulatory advice to ro club GmbH on the design of the business model for teleoperations in the healthcare sector.

  • Advising Astra Zeneca on regulatory issues, including the market launch of a new drug.

Gleiss Lutz

Gleiss Lutz focuses on advising health insurance companies on patients rights, social security, regulatory and medical law, while the team is also increasingly being instructed by medical technology and pharmaceutical companies. Other growth areas include healthcare compliance and transactions. Clients' representation, including mass proceedings, is another mainstay of the practice; here, the practice frequently advises on claims for damages in the context of vaccine-related injuries. This is complemented by expertise in the areas of medicinal cannabis, data protection and digitisation as well as procurement and patent law. The interdisciplinary team is jointly led by Reimar Buchner (statutory health insurance, hospital, pharmaceutical and physician law) and Martin Viciano Gofferje (transactions and joint ventures).

Practice head(s):

Martin Viciano Gofferje; Reimar Buchner

Other key lawyers:

Marco König; Enno Burk; Eike Bicker; Andreas Neun; Christian Hamann


‘Extremely competent and client-oriented approach at eye level.’

‘Excellent law firm for the pharmaceutical industry and the healthcare sector in general.’

‘Marco König is an absolute expert in his field and is very well supported by his team.’

Key clients

AOKen (Bundesverband, Landesverbände)

Bundesministerium für Gesundheit

Paracelsus Kliniken

Klinikum Lippe

Bundesinstitut für Arzneimittel und Medizinprodukte (BfArM)

Curaleaf Holdings, Inc., Vereinigte Staaten von Amerika

Paul Ehrlich Institut

Carl Zeiss Meditec AG


MAYD Group GmbH


Verband der Ersatzkassen e.V. (vdek e.V.)

EuC Management Pty. Ltd

Dr. Sennewald Medizintechnik

Work highlights

  • Advising Curaleaf Holdings, Inc. on the acquisition of a 55% stake in Four 20 Pharma GmbH, a fully EU GMP and GDP licensed German manufacturer and wholesaler of medicinal cannabis.

  • Advising EuC Management Pty. Ltd on the market entry of the telemedicine portal Eucalyptus, which specializes in obesity.

  • Supporting MAYD Group GmbH before various federal state pharmacy supervisory authorities on the legality of the business model, in competition law proceedings as well as in correspondence and evaluation with investors.

Hengeler Mueller

Hengeler Mueller‘s healthcare team cooperates across practices, thus comprehensively covers interfacing matters. Dirk Uwer has expertise in white-collar criminal law and is regularly instructed in connection with internal investigations. Administrative and regulatory expert Wolfgang Spoerr is experienced in contentious proceedings before the relevant authorities, courts and arbitration tribunals; he is also well versed in regulatory matters, including medical device law and interfacing data protection matters, as well as the implementation of compliance management systems. Counsel Susanne Koch is experienced in pharmaceutical law and transaction support, while counsel Erasmus Hoffmann is another key contact and covers the interface between healthcare, data protection and product compliance.

Practice head(s):

Dirk Uwer; Wolfgang Spoerr; Susanne Koch; Erasmus Hoffmann

Other key lawyers:

Alexander Nolte

Work highlights

Latham & Watkins LLP

Latham & Watkins LLP's focus in the healthcare and life sciences sector is on transaction support, where the team is regularly instructed by financial investors and industrial companies. A key strength is the support in US-related transactions, thanks to the close cooperation with the respective locations . The team is led by transaction experts Henning Schneider and Christoph Engeler; the latter also advises on regulatory issues. Associate Henrietta Ditzen is another key contact and assists with transactions and regulatory issues, thereby underlining the overall approach.

Practice head(s):

Henning Schneider; Christoph Engeler

Other key lawyers:

Henrietta Ditzen

Work highlights

McDermott Will & Emery Rechtsanwälte Steuerberater LLP

McDermott Will & Emery Rechtsanwälte Steuerberater LLP‘s advisory offering focuses on three segments: project support (transactions and cooperations), regulation (market entry and licensing) and digitisation. The latter frequently pertains to the development of healthcare apps and databases, including interfacing data protection matters, a key contact here is Deniz Tschammler. Among the client roster are pharmaceutical, medical technology and biotechnology companies; the advice to healthcare funds on transactions and venture capital financing is a recent growth area. Practice head Stephan Rau specialises in M&A transactions as well as regulatory and compliance issues. He is supported by Monika Emilia Richter (implementation and advice on strategic cooperations, licensing, development agreements) and Jana Grieb, who advises pharmaceutical and medical technology companies on various issues, including research and development-related issues as well as market entry, advertising and sales. M&A expert Nadine Hartung joined Raue in March 2023.

Practice head(s):

Stephan Rau

Other key lawyers:

Deniz Tschammler; Monika Richter; Jana Grieb; Lea Hachmeister


‘Technical expertise, efficiency, project knowledge, customer knowledge, international network and years of trusting cooperation in all areas.’

‘I have been working with Stefan Rau for years – excellent lawyer in the areas of statutory health insurance and corporate law. Perfect and always available, very flexible, sharp thinking, very good connections in related legal areas. Last but not least – very good team around the lawyer.’

‘Communication always takes place with the main contact. If needed, internal addition of lawyers who may have particular knowledge in related areas of law. Processing is very quick, communication is uncomplicated and project development is very good. The responsiveness of the key contacts is also very good.’

‘McDermott’s life sciences practice is a beacon of excellence in the legal landscape. What sets them apart is not only their specialist knowledge, but also their reliability. One can always count on McDermott to deliver results that are not only legally sound, but also strategically aligned with company goals.’

‘Monika Richter is an outstanding personality in the legal world. Her extensive knowledge of the life sciences is remarkable. Monika Richter’s ability to translate complex legal concepts into actionable insights has proven time and time again to be invaluable. What really sets Monika apart, however, is her reliability. Her commitment goes beyond the usual legal advice; she takes the time to understand the unique needs of our business and delivers tailored solutions that meet both legal requirements and business objectives.’

‘Monika Richter’s responsiveness and clear communication created a trusting environment in which we felt supported and understood at every stage of the legal process.’

‘Highly competent representation of our positions. Very focused and clear implementation of the mandate.’

‘Outstanding commitment; pragmatic approach; efficient solutions and pleasant handling by Dr. Deniz Tschammler.’

Key clients

Amalgam RX

AUCTUS Capital Partners AG

AXA Konzern AG

Bundesverband der Betreiber medizinische Versorgungszentren

Centric Health Holdings Ltd

Dentsply Sirona

GlaxoSmithKline GmbH & Co. KG

GREENPEAK Partners Advisory GmbH

lifespin GmbH

Myonex Inc

Merck KGaA

PharmaLex GmbH

Ryvu Therapeutics S.A.

Santen SA / Santen GmbH

STADA Arzneimittel AG

Work highlights

NOVACOS Rechtsanwälte

Healthcare boutique NOVACOS Rechtsanwälte comprehensively advises national and international clients in the healthcare, biotechnology, pharmaceutical and chemical sectors, including regulatory issues, market entry and reimbursement as well as product safety and compliance. Another core area of ​​the team is drafting healthcare-related contracts, Maria Heil is a key contact here, the practice also represents clients before the relevant courts and authorities. Christian Stallberg is experienced in matters pertaining to pharmaceuticals, medical devices, cosmetics and chemicals, including pesticides and biocides. Clients also benefit from the team's expertise in healthcare-related digitisation matters, such as  healthcare data protection, procurement law and issues pertaining to the e-health sector. Christian Hübner is well versed in pharmaceutical and pharmaceutical advertising and also focuses on transaction and cooperation support.

Other key lawyers:

Maria Heil; Alexander Natz; Marc Oeben; Christian Hübner; Christian Stallberg


‘High level of technical expertise and political flair.’

‘Christian Hübner is very experienced, well informed, thinks outside the box and has the client’s perspective in mind.’

‘Christian Hübner: Sound, targeted advice, he becomes part of the team and thinks for the client, he doesn’t just advise from the outside.’

Key clients

Rhythm Pharmaceuticals


Work highlights

  • Advising Nordic Capital on the acquisition of corpuls – GS Elektromedizin Geräte G. Stemple GmbH, manufacturer of defibrillators and provider of telemonitoring services.

  • Advising Rhythm Pharmaceuticals on all questions relating to the statutory health insurance system, including the AMNOG procedure and lifestyle medicines.

  • Advising Ultragenyx on market access in Germany.

Taylor Wessing

Taylor Wessing's focus is mirrored in the practice group management: Anja Lunze heads the life sciences segment, while Michael Stein is the key contact for the healthcare sector. Clients benefit from the close cooperation of the corporate, M&A and regulatory teams, where the team regularly supports buyers in transactions in the outpatient and inpatient sectors and in the formation of groups of medical care centers; the team also covers the procurement law interface, including advising hospital chains on the Hospital Future Act and the implementation of IT system, above all, hospital information systems. The focus in the life sciences area is on advising pharmaceutical and biotechnology companies on medical, pharmaceutical, patent and trademark law issues, including product liability and contentious matters. This is completed by capacities in the digital healthcare segment, where the regulatory team frequently cooperates with the TMT practice. Medical law expert Karolina Lange-Kulmann was appointed partner in April 2023, while Stefanie Greifeneder (regulatory, commercial and contract-related matters in the pharmaceutical, medical device and biotechnology sectors; compliance) joined the team the following month from Fieldfisher.

Practice head(s):

Anja Lunze; Michael Stein

Other key lawyers:

Karolina Lange-Kulmann; Stefanie Greifeneder; Daniel Tietjen


‘The Taylor Wessing team has always been very responsive, well prepared and extremely professional.’

‘Collaboration is always fair and based on transparency and a high level of accuracy.’

‘We are impressed by the team’s integrated approach and deep industry know-how. Inquiries are answered quickly, competently and practically. The understanding of the problem, shaped by years of industry experience, and the creativity in problem solving are convincing.’

‘The practice has an extremely high level of competence in all areas. This means that complex issues that do not just affect one regulatory area are dealt with in an interdisciplinary and holistic manner.’

‘Daniel Tietjen has excellent knowledge of competition law, particularly pharmaceutical advertising law, and regularly supports us in this area. I really appreciate the practical but also creative solutions.’

‘The team offers uncomplicated, expert support at all times.’

‘Daniel Tietjen always responds quickly, works very conscientiously and is always very solution-oriented.’

‘Hands-on and strong in teamwork on interdisciplinary cases.’

Key clients



Azenta INC



Daiichi Sankyo

Dana-Faber Cancer Institute

Fresenius Kabi Swiss BioSim


MTK Pharma

NORD Holding




STADA Arzneimittel


Work highlights

  • Advising numerous financial investors and their portfolio companies (including amedes, NORD Holding, Oberberg, Sanecum and Trilantic) on various transactions in the inpatient and outpatient sectors, particularly with regard to the implementation of their respective buy-and-build strategies.

  • Defending AstraZeneca against consumer lawsuits regarding its Covid-19 vaccine.

  • Representing Pfizer in the patent infringement proceedings brought by Moderna regarding the alleged infringement of mRNA vaccine patents (Comirnaty).

A&O Shearman

A&O Shearman follows an interdisciplinary and cross-border approach and advises a diverse client base consisting of pharmaceutical and biotechnology companies, medical technology and diagnostics providers as well as investors and financial services providers. Practice head Alexander Veith is experienced in transaction support; he is supported by counsel Eda Zhuleku, who is well versed pan-European regulatory matters. The latter include the advice on cloud-based digital healthcare platforms in medicine and telemedicine and on healthcare apps as well as reimbursement issues pertaining to medicines. Further competencies are assisting new companies with market entry in the in-vitro diagnostics area as well as supporting health incurance companies in contract-related matters; clients are also represented in patent disputes.

Practice head(s):

Alexander Veith

Other key lawyers:

Eda Zhuleku; Stephan Neuhaus; Hartmut Krause


‘Very well managed team. Quick processing of inquiries at the highest professional level.’

‘Very good collaboration with Eda Zhuleku. She works very quickly and very professionally and always offers very good, practical solutions.’

‘Such perfect cross-functional collaboration within a large law firm is rare. Super fast coordination between the individual areas and the answers, recommendations and elaborations are concise, pragmatic and to the point. Just the way you want it to be as an in-house counsel.’

Key clients

Kyowa Kirin International (KKI)

Novo Nordisk A/S

Carl Zeiss Meditec AG

Bayer AG


Johnson & Johnson

Enovis Corporation

Santhera Pharmaceuticals Holding AG

Vision Healthcare B.V.

VetFamily GmbH

Sleepiz AG


Colosseum AG


Work highlights

  • Advising Kyowa Kirin International on its joint venture collaboration with Grünenthal regarding KKI’s established drug portfolio.

  • Advising Bayer AG on the sale of its men’s health product Nebido™ (testosterone undecanoate) to Grünenthal. The transaction volume totals up to €500 million.

  • Advising Novo Nordisk A/S on the coordination of its pan-European patent dispute regarding Novo Nordisk’s Victoza®/Saxenda® products.

Bird & Bird

Bird & Bird's healthcare expertise includes capacities at the interfaces with IP, procurement law and digitisation as well as contentious issues. Dispute resolution in the life sciences sector is a focus area of the team, which is led by Boris Kreye; Kreye regularly assists with patent infringement disputes in connection with medical devices. Alexander Csaki advises private companies and public sector clients at the interface between procurement and regulatory law, including the advice on selective contracts issued by statutory health insurance companies as well as licensing matters, the interchangeability of drugs and drug prices.

Practice head(s):

Boris Kreye

Other key lawyers:

Alexander Csaki


Dentons is led by Christof Kautzsch and comprehensively advises innovative pharmaceutical manufacturers, hospital groups, health insurance companies as well as companies from the medical device, pharmaceutical, biotechnology and diagnostics sectors, financial investors and research institutions. The practice closely cooperates with other locations as well as with the corporate, M&A, procurement and employment law teams, thereby covering regulatory issues. Kautzsch offers transaction support, while Ilka Mehdorn is well versed in regulatory issues and Peter Homberg advises on matters pertaining to medicinal cannabis. Matters at the interfaces with IP and IT are also covered, where the team represents pharmaceutical companies in trademark and patent disputes as well as in civil and criminal law proceedings in connection with pharmaceutical crime. Homberg also advises on cross-border IP licences, commercial contracts and transactions, he is supported by senior associate Malte Goetz.

Practice head(s):

Christof Kautzsch

Other key lawyers:

Peter Homberg; Ilka Mehdorn; Thomas Strassner; Malte Goetz

Key clients

atai Life Sciences


Bayer AG

BG Kliniken Ludwigshafen und Tübingen gGmbH / BG Kliniken – Klinikverbund der gesetzlichen Unfallversicherung gGmbH



GH Research

HiDoc Technologies

Jeito Life & Brandon Capital

Klinikum Darmstadt

Novartis AG

numares AG

Roche Diagnostics GmbH

Roche Pharma AG und RoX GmbH

Sana Klinik Service GmbH

Schnorrenberg Chirurgiemechanik GmbH (umfirmiert in Medworx GmbH)

Work highlights

  • Advising DEMECAN GmbH on the preparation of a legal opinion on the possibility of legalizing cannabis for recreational purposes in Germany as well as on the legal requirements for a scientific cannabis model project in Germany.

  • Advising a company in the field of digital health on a cooperation agreement with large pharmaceutical companies to develop a better and digitalized healthcare system in Germany. Regulatory and data protection analysis of a concept regarding the development of a project for the processing of raw patient data and their usability in the context of clinical studies.

  • Advising Jeito Life & Brandon Capital on the € 50 million Series C financing for the biotech company CatalYm GmbH.


Dierks+Company is led by the pharmaceutical and medical device law experts and general practitioner Christian Dierks. The practice follows an intergrated and interdisciplinary approach, whereas project management and healthcare-related IT matters are also covered. The team increasingly advises at the interface with ​​public matters, which leads to frequent instructions in the context of legislative proposals. This is complemented by expertise in the development and establishment of innovative products as well as digital healthcare services, including data protection issues. Steffen Schröder is a key contact for matters pertaining to the global distribution of medicines as well as the research and development of medicines and their international licensing. In October 2023, counsel Katrin Helle (regulatory law) joined the team at White & Case LLP, while Dominik Roters, general counsel and deputy managing director of the Federal Joint Committee (G-BA), joined the team in January 2024; he is experienced in advising on pharmaceuticals and statutory health insurance.

Practice head(s):

Christian Dierks

Other key lawyers:

Ulrike Knirsch; Steffen Schröder; Dominik Roters


‘Very experienced teams – always with the correct breadth and depth in the requested topics – top!’

‘Our experiences have been positive all around, response times are quick and the service overall is very positive.’

‘Both Christian Dierks and his secretary and assistant are reliable; Competence in discussions and developing solutions. Deadlines will be adhered to.’

Key clients

Aignostics GmbH

Alexion Pharma Germany GmbH

Alnylam Pharmaceuticals

Angelini Pharma

Apotheke im Elisenpalais

Bencard Allergie



Bundesministerium für Gesundheit (BMG)

Bundesverband der Pharmazeutischen Industrie e.v. (BPI)

Burg Pharma

Bundesverband Medizintechnologie e. V.

Cerus Corporation

Cord Blood Center

DIERS International GmbH



epitop GmbH

Esper Bionics


Flatiron Health Inc

Gesundes Kinzigtal GmbH

GHD GesundHeits GmbH Deutschland


“HIT” (HEALTHCARE IT-Solutions GmbH)


Johnson & Johnson

Kenbi GmbH

Kaufmännische Krankenkasse – KKH

Krystal Biotech

Labor Becker

Labor Berlin

Medevice – Medizinische Geräte GmbH


Medios AG

MedTech Europe





Mirati Therapeutics

Merck Sharp & Dohme

Ocumeda AG



Pfizer Pharma GmbH

Retrobrain R&D

RR Technologies

Samsung Electronics GmbH

Santen Pharmaceutical

Sedana Medical

SHL Telemedizin


Therakos (UK) Ltd

Universitätsklinikum Essen

Universitätsklinikum Tübingen

Vision Zero

Vivira Health Lab GmbH

XO Life

Zambon GmbH

Zur Rose Group

Work highlights

  • Support for change4RARE in the initiative of the same name, through which knowledge about the care of rare diseases is bundled with the active involvement of various specialist disciplines and perspectives and made accessible to an interested (professional) public; Advice, among other things, on the design of the initiative as well as the content and structural development; In addition, strategic support of the communication campaign.

  • Support in setting up the NUM (National Network for University Medicine), including all essential contracts and data protection documents.

  • Support for the EHDS coalition project in the development of position papers, formulation aids, reports and concepts for the communicative support of these products in political and legislative processes for the design of the EHDS regulation.

Friedrich Graf von Westphalen & Partner

Led by the pharmacy law expert Morton Douglas and the commercial and corporate law specialist Jan Henning Martens, Friedrich Graf von Westphalen & Partner supports large pharmaceutical companies, biotechnology start-ups, medical device manufacturers, pharmacies, laboratories, hospitals and care facilities in all matters under health law. Interfacing corporate law and M&A matters are frequently covered by Hendrik Thies and Meike Kapp-Schwoerer, while Sabine Schröter handles the interface with employment law, including reorganisations. The team is also experienced in model proceedings pertaining to pharmacy law as well as pharmaceutical advertising law.

Practice head(s):

Jan Henning Martens; Morton Douglas

Other key lawyers:

Hendrik Thies; Sabine Schröter; Meike Kapp-Schwoerer


‘Dr. Sabine Schröter: The expertise goes far beyond her specialist area, as she also has an outstanding wealth of experience in business and economics.’

Key clients

APO Pharma Immun GmbH

Apothekerkammer Nordrhein

Bentley InnoMed GmbH

Deutsche Fach-pflege Gruppe Holding GmbH

Dr. Langer Medical GmbH

Dt. Versandapotheke Fliegende Pillen

Essilor International S.A.


Lenus GmbH

Paracelsus Kliniken Deutschland GmbH & Co. KGaA


Pulsion Medical Systems S E

RED Medical Systems GmbH

Tillotts Pharma AG

VDARZ – Bundesverband Deutscher Apothekenrechenzentren

Work highlights

  • Ongoing advice to the North Rhine Association of Pharmacists on numerous model proceedings before German and European courts.

  • Advising Bentley InnoMed GmbH on the MedTech deal with Upstream Peripheral Technologies.

  • Advising the shareholders of Dr. Langer Medical GmbH on the sale of the company to Brainlab AG.

King & Spalding LLP

King & Spalding LLP focuses on regulatory advice in the life sciences sector at the interfaces with food, pharmaceutical and medical device law, which leads to frequent instructions pertaining to product launches, market entry and recalls as well as compliance. The team also represents clients in competition law proceedings, such as parallel import proceedings. This expertise is evident in a recently obtained groundbreaking judgment for the pharmaceutical market, where practice head Ulf Grundmann took the lead. Counsel Elisabeth Kohoutek complements this with experience in M&A transactions, here, the practice regularly cooperate with the international network.

Practice head(s):

Ulf Grundmann

Other key lawyers:

Elisabeth Kohoutek


‘King & Spalding is one of the leading law firms for parallel trade cases and trademarks in the pharmaceutical industry. They have represented various pharmaceutical companies at all judicial levels, including before the Court of Justice of the European Union.’

‘King & Spalding has deep expertise in trademark law for the pharmaceutical industry.’

‘Ulf Grundmann is very experienced. What sets him apart is his ability to think outside the box – his legal strategies are very creative yet highly effective.’

Key clients

Novartis Pharma AG

ratiopharm GmbH

GlaxoSmithKline Consumer Healthcare GmbH & Co. KG (GSK Consumer Healthcare

biomo Group

Angelini Pharma Deutschland GmbH

Teva Pharmaceuticals Europe B.V. und Teva GmbH

Dr. Willmar Schwabe GmbH & Co. KG

Deutsche Homöopathie-Union DHU-Arzneimittel GmbH & Co. KG (DHU)

Roche Diagnostics

Chemische Fabrik Kreussler Co. GmbH

DR. KADE Pharmazeutische Fabrik GmbH

Diagnostic Green

SGF International e.V.

Eckes-Granini Group

Heilerde-Gesellschaft Luvos Just GmbH & Co. KG


AgNovos Healthcare

Work highlights

  • Representation of Novartis Pharma AG as the original manufacturer in the submission procedure before the ECJ regarding the parallel import of pharmaceuticals.

  • Advising GSK Consumer Healthcare in a competition dispute regarding advertising claims for the Vitasprint Pro Immun product.

  • Advising the French medical technology company MODJAW SAS in a competition dispute against zebris GmbH in connection with a medical device and its classification as a medical device.


Linklaters' healthcare team is integrated into the global healthcare and life sciences group, thus covers cross-border matters, including transactions, restructuring and joint ventures. The practice is led by Jana Hager, who joined the partner roster in May 2023. Clients stem from the pharmaceutical, biotechnology, medical devices and healthcare services sectors and frequently instruct the team on interfacing corporate and M&A matters as well as regulatory issues in the area of ​​product liability and safety, including related disputes, as well as ​​compliance. Bolko Ehlgen and Julia Schönbohm both complement this offering with expertise in patent law as well as in the digital healthcare and data protection segments.

Practice head(s):

Jana Hager

Other key lawyers:

Bolko Ehlgen; Julia Schönbohm

Work highlights

  • Advising GlaxoSmithKline in a tender process for the award of a so-called pandemic preparedness contract, including negotiations with the Federal Republic of Germany, as well as advising on negotiations with the consortium partner CureVac. Additionally, advice on liability and exemption clauses in the pandemic preparedness contract.

  • Advice to Carlyle and PAI Partners on the acquisition of Theramex, including regulatory advice relating to the investigation of regulatory compliance and product risks and the related contractual drafting.

  • Advising Fresenius SE & Co. KGaA and its committees on the deconsolidation of its subsidiary Fresenius Medical Care AG & Co. KGaA by means of a change of legal form into a stock corporation.

Luther Rechtsanwaltsgesellschaft mbH

Led by Oliver Kairies (Hannover), of counsel Cornelia Yzer (Berlin) and Denis Ullrich (Leipzig), Luther Rechtsanwaltsgesellschaft mbH 's healthcare and life sciences team offers cross-practice advice on transactions (above all in the hospital sector) and the market launch of medical devices (where the team frequently assists pharmaceutical and medical device manufacturers with related regulatory matters) as well as distribution law and product liability. The digital healthcare segment includes expertise in IT, IP and data protection, which leads to regular instructions by foreign investors in the context of smart healthcare solutions; traditional medical device manufacturers are also among the client roster.

Practice head(s):

Oliver Karies; Cornelia Yzer; Denis Ullrich

Other key lawyers:

Thomas Gohrke; Eva-Maria Rütz; Hendrik Bernd Sehy


‘Quick response times and appointment scheduling for coordination.’

Key clients

IDT Biologika GmbH


ZytoService Beta GmbH

Mehiläinen Oy


Ottobock MedicalCare GmbH

Land Brandenburg

Landkreis Oberspreewald-Lausitz

Städtisches Klinikum Braunschweig gGmbH

Klinikum Niederlausitz GmbH

Stadt Köln

Universitätsmedizin Göttingen

Medizinische Hochschule Hannover

Universität Siegen

Verwaltungs-Berufsgenossenschaft (VBG) gesetzliche Unfallversicherung

Work highlights

  • Advising Mehiläinen Oy on the acquisition of an MVZ chain.

  • Advising the state of Brandenburg on the development of the Lausitz model for a new type of university medicine.

  • Legal and tax advice to QIMA Ltd. on the acquisition of 100% of the shares in MONASTERIUM LABORATORY – Skin & Hair Research Solutions GmbH.

Meisterernst Rechtsanwälte

Meisterernst Rechtsanwälte places a dual focus on pharmaceutical and food law and advises clients from the pharmaceutical and medical device sectors on competition law and pharmaceutical advertising law issues, including litigation. The latter also includes landmark proceedings, where practice head Christian Tillmanns frequently takes the lead. Recent instructions include advising pharmaceutical companies on price negotiations and cost-benefit assessments. Markus Fuderer was appointed partner in January 2023; he is well versed in matters pertaining to technology, including software solutions and AI, as well as cybersecurity and data protection.

Practice head(s):

Christian Tillmanns

Other key lawyers:

Sylvia Braun; Markus Fuderer


‘Dr. Christian Tillmanns and Sylvia Braun represented us extremely competently and successfully in and out of court.’

‘In addition to the advertising law and procedural expertise and experience of the team led by Dr. Christian Tillmann’s breadth of consulting practice should also be emphasized.’

‘The advice is characterized in particular by the extensive experience, high level of professional expertise, great pragmatism and targeted focus. Particularly noteworthy are the tactical skills and the great competence and experience in competitive processes.’

Key clients

Alnylam Germany GmbH / Alnylam Switzerland GmbH

Amicus Therpeutics GmbH

Lifescan Deutschland GmbH

Queisser Pharma GmbH & Co. KG

Salus Haus Otto Greither GmbH & Co. KG

Work highlights

  • Supporting the preparation of the market entry of new products for the biopharmaceutical company Alnylam, headquartered in the USA; In addition, ongoing advice and representation on pharmaceutical advertising law.

  • Ongoing advice to Amicus Therapeutics GmbH on approval and contract law, on clinical studies and cooperation agreements with medical centers, on sales and advertising law as well as on compliance; recently also provided advice and representation in connection with AMNOG proceedings in price negotiations on reimbursement contributions with the National Association of Statutory Health Insurance Funds following the extension of approval for medicinal products; also advice on benefit assessment matters with the Federal Joint Committee.

Möhrle Happ Luther

Möhrle Happ Luther's life sciences team focuses on pharmaceutical and pharmaceutical advertising law advice – Julia Luther is a key contact here – as well as on AMNOG proceedings, market access, reimbursement issues and compliance, which are key strengths of Henning Anders. The practice is regularly instructed by pharmaceutical companies, medical device and digital healthcare app manufacturers, hospitals, medical care centers and medical facilities. Joachim Jung is experienced in supporting digitisation projects.

Other key lawyers:

Henning Anders; Julia Luther; Joachim Jung


‘Henning Anders has excellent knowledge of the life sciences/pharma sector.’

‘The personal nature, always cheerful and cheerful, always 150% spot-on and no matter how tight the deadlines are, MHL always has a suggested solution.’

‘Julia Luther’s team offers very thorough, reliable legal advice that is closely tailored to the needs of the client.’

‘Working with the team’s lawyers is uncomplicated, solution-oriented and always a pleasure.’

‘Great team with many different skills. This applies to all areas and the entire team. You get quick feedback at any time.’

‘Pragmatic and legally high-quality feedback/assessments within a short time.’

‘Quick accessibility, pragmatic approaches to solutions, solution-oriented.’

‘Many years of experience with competition law disputes in the pharmaceutical sector. Very good commitment to the interests of the client. Fast and efficient work. Clear and comprehensible recommendations and decision support.’

Key clients

Almirall Hermal GmbH

Amgen GmbH

AstraZeneca GmbH

Pfizer Pharma GmbH/ Pfizer Deutschland GmbH/

Novartis Pharma GmbH

Work highlights

  • Ongoing advice to AstraZeneca GmbH on, among other things, advertising campaigns, healthcare compliance, digital projects; here in particular on digital marketing and regulatory issues in connection with the integration of medical apps. Additionally, representation in litigation in the areas of diabetes, heart disease, renal insufficiency, asthma, COPD and oncology.

  • Advising Amgen GmbH on questions relating to pharmaceutical advertising law, including support in out-of-court and contentious disputes.

  • Advising Pfizer Pharma GmbH on pharmaceutical advertising law, particularly in the area of ​​vaccines, as well as trademark law support, including in-court and out-of-court support.

Oppenländer Rechtsanwälte

Led by Timo Kieser, Christina Koppe-Zagouras and Katharina Köbler, Oppenländer Rechtsanwälte's team focuses on the areas pharmaceuticals, pharmacies and medical devices. The team assists with regulatory issues and proceedings before the authorities as well as labeling and marketing-related matters pertaining to competition, pharmaceutical advertising and distribution law. A recent focus was on digitisation matters in the healthcare sector as well as regulatory issues in connection with medicinal cannabis. The practice frequently assists with contentious proceedings in the pharmacy sector.

Practice head(s):

Timo Kieser; Katharina Köbler; Christina Koppe-Zagouras


‘Dr. Katharina Köbler: Very fast response times, practical solution suggestions, extreme clarity even on complex topics, communicates the topics in an understandable manner,  focuses and limits herself excellently to what is necessary.’

Key clients

GlaxoSmithKline Consumer Healthcare GmbH & Co. KG

WEPA Apothekenbedarf GmbH & Co. KG


PHAGRO Bundesverband des pharmazeutischen Großhandels e.V.

Reckitt Benckiser Deutschland GmbH

Accord Healthcare GmbH

Accord Healthcare Ltd. (UK)

Accord Healthcare Ltd.

Accord Healthcare S.L.U.

Andreas Hettich GmbH & Co. KG

Herbert Waldmann GmbH & Co. KG

Biologische Heilmittel Heel GmbH

Metronomia Holding UGHMD Services GmbH

Intas Third Party Sales 2005 S.L.U. (INTAS B2B)

Dr. Falk Pharma GmbH

Bioloving Germany Biotech GmbH & Co. KG

Vapotherm Inc.IFA GmbH

KLINGEL medical metal GmbH

Work highlights

  • Ongoing advice to Accord HealthCare Ltd. and Accord Healthcare GmbH on all procurement, antitrust and pharmaceutical law issues in connection with discount contract tenders from all major health insurance companies.

  • Advice on pharmaceutical and medicinal products law to GlaxoSmithKline Consumer Healthcare GmbH & Co. KG; Recently, support in a dispute with competitors regarding, among other things, OTC preparations.

  • Supporting IFA GmbH in the procurement and social security law statement on the calculation of manufacturer discounts in accordance with Section 131 Paragraph 4 SGB V. The statement concerns questions in the area of ​​contract awarding in the social insurance and health sector as well as the interaction of association agreements and legal regulations.

Osborne Clarke

Osborne Clarke's team routinely advises on IP law issues in patent infringement proceedings, while the regulatory expertise is called upon in matters pertaining to pharmaceutical advertising law. This is complemented by capacities at the corporate law interface, such as the advice on pharmaceutical cooperation and licensing agreements, including cross-border transactions, as well as experience in supporting digitisation projects. The project work frequently pertains to patient care and treatment in connection with healthcare platforms. AI-related topics in the medical device segment and related data protection issues are also covered, practice head Tim Reinhard is a key contact here.

Practice head(s):

Tim Reinhard

Other key lawyers:

Andrea Schmoll; Flemming Moos; Fabian Christoph


‘Andrea Schmoll: Very pleasant in management matters, is very aware of the specialist knowledge in her team as well as in the firm and actively involves relevant colleagues to ensure consistently high quality.’

‘Dedicated team that works well with new inquiries.’

Key clients

Bruker Gruppe Deutschland (Bruker EAS, Bruker HTS, Bruker BioSpin, RI Research)

CEVEC Pharmaceuticals GmbH

Fresenius SE

Gerresheimer AG

Haema AG

PharmaDrug, Inc.

VAMED Rehazentren Deutschland GmbH

Grifols Deutschland GmbH

Work highlights

  • Advice and support for the Bruker Group Germany on various projects, including dismissal protection procedures, realignment of the BASC division and design and implementation of a new working time and time recording system.

  • Supporting Fresenius SE in the planning and implementation of a project to convert any active contractual relationships based on the old EU standard contractual clauses to the new EU standard contractual clauses.

  • Advising PharmaDrug, Inc. on the sale of all shares of its German subsidiary Pharmadrug Production GmbH to Khiron Life Sciences Corp.

Preu Bohlig & Partner

Preu Bohlig & Partner specialises in pharmaceutical, competition and cosmetics law and routinely advises pharmaceutical and medical device companies on issues pertaining to the licensing, development and marketing of pharmaceuticals. This offering is complemented by Daniel Hoppe's patent law expertise as well as Alexander Meier's experience in product liability and life sciences compliance; Meier is also experienced in the area of ​​orphan drugs. Both are key contacts of the practice led by Peter von Czettritz; von Czettritz is well versed in third-party opposition proceedings.

Practice head(s):

Peter von Czettritz

Other key lawyers:

Alexander Meier; Daniel Hoppe; Tanja Strelow


‘Peter von Czettritz: Expertise and experience in pharmaceutical and medical device law.’

Key clients

Moderna Therapeutics, Inc.

Formycon AG

LFB Laboratoire Francais du Fractionnement et Biotechnologies SA

MIT Gesundheit GmbH

Work highlights


Raue's Berlin-based team is jointly led by Katharina Wodarz (transaction support, physician contract law, pharmaceutical pricing and pharmacy law, contentious proceedings before authorities and courts) and Maren Bedau (hospital sector, physician contract law, nursing care companies, compliance). Former practice head Wolfgang Kuhla moved to of counsel status (he continues to advise on planning and financing issues as well as on the drafting of cooperation agreements and physicians' contracts). The team focuses on regulatory advice and transaction support, which benefits investors, start-ups, hospitals, medical care centers, pharmaceutical and medical device companies and mail order pharmacies. The transaction capacities were strengthened with the addition of Nadine Hartung from McDermott Will & Emery Rechtsanwälte Steuerberater LLP in March 2023. Thanks to cross-practice cooperation, various interfacing matters, including IP, employment and competition law are also covered.

Practice head(s):

Maren Bedau; Katharina Wodarz

Other key lawyers:

Nadine Hartung; Wolfgang Kuhla


‘Maren Bedau: Excellent availability and communication. Speed ​​in the projects and absolute specialist knowledge.’

‘Raue has extensive experience in supporting setting up medical care centers. They maintain good relationships with the committees of the statutory health insurance self-administration, which enables regulatory questions to be clarified at an early stage of the project and leads to the smoothest possible process.’

‘The law firm combines the highest legal quality with pragmatic solutions and fast response times.’

‘Dr. Maren Bedau: Excellent competence in general and specific questions of medical and social law. Outstanding, clear communication, high availability and extraordinary commitment.’

‘Dr. Katharina Wodarz: Solution-oriented and reliable.’

Key clients

DocMorris NV


Landkreis Trier Saarburg


Kirinus Health

DRK Kliniken Berlin

Schön Klinik SE

Kliniken Nordoberpfalz AG

Proteopath GmbH

Labor Berlin

Sonic Healthcare Germany

Deutsches Herzzentrum Berlin (DHZB)


Eterno Health

DIZG Deutsches Institut für Zell- und Gewebeersatz gGmbH

Johanniter-Krankenhaus Treuenbrietzen

Advita Pflegedienst GmbH

MIA Medical Information Analytics GmbH

Sanofi-Aventis Deutschland GmbH

Work highlights

  • Representation of DocMorris NV in landmark proceedings regarding the admissibility of online marketplaces for pharmacy products.

  • Advising Sanofi on the market launch of DiGas, including cost reimbursement.

  • Representation of the DRK Kliniken Berlin Köpenick in a model lawsuit against the state of Berlin. The proceedings are directed against the co-financing of municipal hospitals from the state budget, which, from the perspective of Berlin’s 29 hospital operators, distorts competition.

DLA Piper

DLA Piper 's life sciences practice follows a cross-location and cross-sector approach, thus routinely advises on large-scale transactions in the healthcare sector. Patent litigator Philipp Cepl and Kokularajah Paheenthararajah (patent and license litigation) jointly head the team; the latter is also a qualified physician and joined the partner roster at the same time as Moritz von Hesberg (M&A) in May 2023. The team focuses on transaction support, patent law and interfacing regulatory matters, including the advertising and marketing of medical devices, market access and compliance as well as research agreements. EU regulatory issues are handled thanks to the cooperation with the EU life sciences regulatory practice, which launched in February 2023. Digital healthcare matters are covered thanks to the cooperation with the data protection and IT team.

Practice head(s):

Kokularajah Paheenthararajah; Philipp Cepl

Other key lawyers:

Thilo Streit; Moritz von Hesberg

Key clients


Work highlights

  • Advising ResMed on the acquisition of MEDIFOX DAN, a leading German provider of software solutions for out-of-hospital care, from HgCapital, a private equity investor in the technology and services sector.

Ehlers, Ehlers & Partner

Ehlers, Ehlers & Partner specialises in medical law and impresses with its expertise in AMNOG and legislative proceedings. Other competencies include the advice on market access, product development and compliance issues as well as issues at the digitisation interface; the latter includes telematics, data protection, digital medical devices and digital healthcare services. Among the client roster are pharmaceutical companies and medical device manufacturers, which also benefit from the team's experience in restructuring and transactions. The practice is led by medical lawyer Alexander Ehlers and Christian Rybak, who is regularly instructed by US-based clients.

Practice head(s):

Alexander Ehlers; Christian Rybak

Other key lawyers:

Julian Bartholomä


‘An exceptional team.’

‘Christian Rybak: An absolute expert on all health policy and legal issues with an incomparable network at the political levels and with all important stakeholders in the healthcare system in Berlin.’

‘Diverse team, always well informed, oriented towards solutions.’

‘Alexander Ehlers: Good leader, charming, excellently connected.’

‘Christian Rybak: Excellently informed, good conversationalist, committed and ready to work.’

‘Julian Bartholomä: Excellent lawyer with vision and good understanding of the market. Excellently networked.’

‘Combination of legal expertise with a business strategic focus.’

Key clients

Bundesministerium für Gesundheit

CKM Shared Services GmbH

CSL Behring

CytoSorbents Europe



Jazz Pharmaceuticals

LEO Pharma

Haemonetics Corporation

MSH Europe


LeMaitre Vascular, Inc.

Reaction Biology Corporation


Work highlights

  • Advising a pharmaceutical company on the implementation of new reimbursement options.

  • Advising a MedTec company on the takeover of a competitor.


Fieldfisher advises pharmaceutical, biotechnology and medical technology companies, healthcare providers and medical technology start-ups on regulatory market entry for medical devices and pharmaceuticals, including related clinical trials, conformity assessment procedures and licensing issues, as well as on compliance and transactions. This mirrors the focus of practice head Cord Willhöft.

Practice head(s):

Cord Willhöft


‘Excellent lawyers, who respond to the needs of customers and always find the right solution. Diverse dedicated teams that also offer a good balance of partners and associates.’

‘Cord Willhöft: Proven expert in the life sciences sector; experienced, precise, pragmatic.’

Key clients

Asahi Kasei Bioprocess

Butterfly Networks, Inc.

Corvia Medical

Galvanize Therapeutics

Ideaya Biosciences

Jena Valve

Medicaroid GmbH

Priocept BioRobotics Inc.

Procept BioRobotics Inc.

Pulmonx Sarl und Pulmonx Co.

ResMed GmbH & Co KG

Starkey Inc.

ZOLL CMS GmbH und ZOLL Medical Corporation

Work highlights

  • Advising Pulmonx Sarl and Pulmonx Co on market access, healthcare compliance and sales as well as regulatory issues.

  • General legal advice to ResMed GmbH & Co KG as well as advice on transactions and real estate.

  • Legal and strategic advice to ZOLL CMS GmbH and ZOLL Medical Corporation on reimbursement of medical aids, healthcare compliance, contract drafting and data protection (GDPR).

GÖRG Partnerschaft von Rechtsanwälten mbB

GÖRG Partnerschaft von Rechtsanwälten mbB advises on pharmacy, pharmaceutical, medical device and hospital law and is regularly instructed by health insurance companies, private and public clinics, nursing care facilities, pharmacies, medical device manufacturers and investors. The regulatory segment is led by co-head Marc Schüffner (Berlin), while co-head John-Patrick Bischoff (Hamburg) is well versed in healthcare-related transactions. The latter area was further strengthened with the arrival of Markus Söhnchen in August 2023 (previously co-practice head at GSK Stockmann). The interdisciplinary approach also covers interfacing real estate, corporate, procurement, IP and employment law matters.

Practice head(s):

Marc Schüffner; John-Patrick Bischoff

Other key lawyers:

Katja Kuck; Markus Söhnchen


‘Very strong combined knowledge of corporate and medical law.’

‘Easy accessibility of the partners combined with a high level of competence and flexibility in difficult legal questions.’

‘Absolutely error-free work, great care and excellent adherence to deadlines.’

Key clients

amedes Medizinische Dienstleistungen GmbH

Carl-Thiem-Klinikum Cottbus gGmbH

Endoprothesenregister Deutschland GmbH

Gemeinsamer Bundesausschuss

Heidekreis-Klinikum gGmbH

Heidelberg Pharma AG


Insulet Corporation

Landesamt für Arbeitsschutz, Verbraucherschutz und Gesundheit (LAVG) des Landes Brandenburg

Livica GmbH

Main-Kinzig-Kreis (MKK)

Morphosys AG


PubliCare GmbH

Rentschler Biopharma SE

Schmerzzentrum Berlin / Schmerzklinik Berlin

SCPI Pierval Santé

SMH Schnelle medizinische Hilfe GmbH

TERTIANUM Seniorenresidenzen/DPF AG

Ufenau Capital Partners AG

UKSH Universitätsklinikum Schleswig-Holstein AöR

Work highlights

  • Advising amedes on the acquisition of  general medical practices in Germany.

  • Advising the Oberbergkliniken on project developments, particularly in health law, tenancy law, labor law as well as various compliance and medical law topics.

  • Advising Ufenau Capital Partners on the restructuring of the shareholder relationships of the Altano Group and the Corius Group.

GSK Stockmann

GSK Stockmann team is led by Maritheres Palichleb, who specialises in supporting national and international institutional investors in nursing care real estate investments and transactions as well as VC investments in start-ups in the healthcare, biotechnology and medical technology sectors. Former co-head Markus Söhnchen (corporate and M&A) joined GÖRG Partnerschaft von Rechtsanwälten mbB in August 2023. Other competencies include the advice on compliance, including matters pertaining to the Hospital Future Act, such as the modernisation of hospitals, digital infrastructure and safeguarding of emergency capacities.

Practice head(s):

Maritheres Palichleb


‘Very good, strong team both professionally and personally.’

Key clients

DLE Living GmbH

ENDRA Life Sciences Inc.

G. Pohl-Boskamp GmbH & Co. KG

Haemonetics GmbH

Integra LifeSciences Corporation

Medraxa Terhapeutics GmbH

Primonial REIM Germany AG

Vetter Pharma-Fertigung GmbH & Co. KG

WELL Health Ventures Inc., Horizons Ventures

Work highlights

  • Advising Medraxa Terhapeutics GmbH on CMS structure and business partner due diligence.

  • Ongoing advice to DLE Living GmbH on the acquisition of nursing care properties, including corporate law and tax transaction structuring of asset deals and share deals, due diligence, purchase agreement, financing.

  • Advising Target Global on a follow-up round of financing for the Berlin company Patient 21.

Harmsen Utescher

Harmsen Utescher specialises in IP law and routinely assists with healthcare-related patent litigation and pharmaceutical advertising issues, as well as interfacing pharmaceutical, food and cosmetics law matters, including parallel imports and product launches. Practice head Rainer Kaase boasts similar competencies and regularly assists with contentious matters before German and European courts. The client roster includes pharmaceutical companies and medical device manufacturers.

Practice head(s):

Rainer Kaase

Other key lawyers:

Andrea Marx

Key clients



Neubourg Skin Care

Work highlights

  • Advising STADA and various group companies on the areas of HWG, parallel imports, soft IP, IP transactions and M&A.

  • Advising Neubourg Skin Care on the area of pharmaceutical advertising law as well as on the areas of pharmaceuticals/medical devices/cosmetics; also assistance with new product launches.

  • Representation of Astellas Pharma in pharmaceutical advertising proceedings.

michels.pmks Rechtsanwälte

Cologne-based michels.pmks Rechtsanwälte impresses with medical law expertise, which is called upon by hospitals, medical care centers, medical practices and healthcare companies. Kerrin Schillhorn focuses on the inpatient care area and jointly heads the practice with Jens-Peter Jahn, who primarily advises on outpatient care facilities. Matters at the interface between medical and employment law are handled by Jannis Kamann and Marcus Michels.

Practice head(s):

Kerrin Schillhorn; Jens-Peter Jahn

Other key lawyers:

Jannis Kamann; Marcus Michels


‘Dr. Kerrin Schillhorn is very experienced, always up to date legally and absolutely reliable.’

‘Jens-Peter Jahn is a proven expert in physician contract law and (dental) medical corporate law with the highest level of competence and experience. The same applies without reservation to Dr. Kerrin Schillhorn in the area of ​​hospital law.’

‘Really available at any time. Highly competent, best networking at the administrative levels and therefore pragmatic and excellent solutions.’

‘Deep into the subject matter. Fastest solutions.’

‘Jens-Peter Jahn: Reliable, experienced, good.’

‘Available at any time, friendly and competent. Good and well-managed substitute situations. All skills available and good network drawing on external skills.’

‘I was able to gain experience with several specialist lawyers from michels.pmks. I felt like I was in very good hands and received excellent advice from every single one of them.’

‘Miss Dr. Kerrin Schillhorn has excellent expertise in all topics relevant to hospital planning.’

Key clients

Katholische Hospitalvereinigung Weser-Egge gGmbH

Krankenhaus Porz am Rhein GmbH

Kreisklinikum Siegen GmbH

Marien Gesellschaft Siegen gGmbH

MVZ am St. Marien-Hospital Friesoythe gGmbH

MVZ Med Center GmbH Siegen

MVZ des Universitätsklinikums Köln gGmbH

MVZ St. Marien GmbH

St. Franziskus-Stiftung Münster

St. Vinzenz Krankenhaus GmbH Köln

Universitätsklinikum Köln AöR

Vestische Caritas-Kliniken gGmbH

Work highlights

  • Advice on hospital law and representation of the Catholic Hospital Association Weser-Egge gGmbH with regard to cooperation with branches and other service providers as well as support in hospital planning.

  • Advice on physician contract law and representation of the medical care center of the University Hospital of Cologne gGmbH before the admissions and appointment committee as well as the KV.

  • Strategic hospital law advice to the St. Franziskus Foundation and its 15 hospitals with over 4,000 beds, including hospital planning, basic questions, organizational requirements for hospitals as well as advice on structural audits according to StrOPS-RL.


Noerr's practice closely cooperates with the M&A team and frequently assists with transactions pertaining to nursing care facilities, hospitals, medical care centers and medical devices. The team offers further cross-practice capacities in the digital healthcare segment, where expertise in digital commerce and life sciences matters is combined. The practice is led by food law specialist Evelyn Schulz; she is supported by Susann Jahn, who is experienced in regulatory matters and joined the partner roster in early 2023.

Practice head(s):

Evelyn Schulz

Other key lawyers:

Susann Jahn

Key clients

Ada Health

Advokatfirman Vinge


Arrow Generics



Butler Snow

Carl Zeiss

Casa Verde Capital


Cerner Corporation

Debeka Krankenversicherung

Doctor mi! GmbH

DRK Kliniken Nordhessen

Ergon Capital Partners

Europäische Investitionsbank


Fresenius Medical Care


Helios Kliniken GmbH

Hera Residenzen Pflege

Home Shopping Europe GmbH


Laureus Capital



Loyens & Loeff


New Flag


Procter & Gamble

Qualitätssicherungs-Initiative Pathologie QuIP

Regeneron Pharmaceuticals Inc

Stada Arzneimittel AG

Wacker Biotech

Wir für Gesundheit

Work highlights

  • Advising Ada Health on medical device law and data protection issues.

  • Advising a leading generic drug manufacturer on the defense of antitrust claims for damages following the European Commission’s fine decision in Lundbeck due to an alleged delay in placing a generic drug on the market.

  • Advising the Else Kröner-Fresenius Foundation on the ongoing reorganization of the Fresenius Group.


Oppenhoff's interdisciplinary team advises pharmaceutical manufacturers, biotechnology companies, hospitals, nursing homes, health insurance companies and care providers on day-to-day business operations and also focuses on M&A transactions and venture capital investments. Co-practice head Gabriele Fontane covers the corporate, M&A and private equity interface and jointly heads the team with Peter Klappich, who is a key contact for litigation and arbitration and also advises on regulatory, competition and commercial law. This is complemented by expertise in the medicinal cannabis segment, where the team recently assisted with the cross-border negotiations of supply contracts as well as the regulatory advice on related import and export issues.

Practice head(s):

Gabriele Fontane; Peter Klappich

Other key lawyers:

Jürgen Hartung

Key clients

Aphria Inc.

Dr. August Wolff GmbH & Co. KG Arzneimittel

LR Health & Beauty Bristol-Myers Squibb GmbH & Co. KGaA

Johnson & Johnson GmbH

Evonik Industries AG

Shop Apotheke Europe N.V.

CC Pharma GmbH

Ecolog Deutschland GmbH

CNP Pharma

Work highlights

  • Expert opinion for Johnson & Johnson in connection with the permissibility of the use of medical data.

  • Representation of several doctors in the sale of Nephrologicum Westfalen, one of the largest independent providers of nephrology and dialysis care services in North Rhine-Westphalia, to the financial investor Adiuva.

PPP Rechtsanwälte

PPP Rechtsanwälte specialises in the healthcare sector and covers all aspects of medical and health law in the outpatient and inpatient segments and complements this with expertise in employment, social security, data protection and tax law. The team is regularly instructed by healthcare institutions on the entire value chain, including formation and licensing,  M&A, restructuring and litigation. The team is led by Andreas Penner , Tanja Koopmann-Röckendorf and André Bohmeier in Düsseldorf, Ute Pittrof in Ingolstadt, Felix Reimer in Heilbronn and Matthias Wallhäuser in Bergisch Gladbach. Hospital and tax law specialist Benjamin Liedy (previously at Schick und Schaudt Rechtsanwälte ) joined the  newly established Tübingen location in May 2023; Claudia Mareck advises service providers on hospital and physician contract law as well as e-health matters and joined the team in January 2024 from KMH Medizinrecht.

Practice head(s):

Andreas Penner; Felix Reimer; Ute Pittrof; Matthias Wallhäuser; Benjamin Liedy; Tanja Koopmann-Röckendorf; André Bohmeier

Other key lawyers:

Claudia Mareck

Key clients

Krankenhausweckverband Rheinland

Sikomed Unternehmensberatung Göttingen

KMG Kliniken SE


Bergisches Zentrum Kardiologie Angiologie

Work highlights

  • Supporting a client in the constitutional complaint against the decision of the Federal Social Court of January 24, 2023 (B 1 KR 7/22 R) pertaining to the so-called Nikolausbeschluss.

  • Supporting Ategris, Rehanova and the Rhein-Neuss-Kliniken in the development of a catalog of criteria for the nationwide updating of hospital planning in North Rhine-Westphalia.

  • Advising KMG Kliniken SE on restructuring in hospital care through concentration, closure and relocation in several federal states.

Schmidt, von der Osten & Huber

Schmidt, von der Osten & Huber is experienced in hospital law and also advises medical and non-medical service providers, investors, start-ups and health insurance companies on all issues of medical and health law. The team also covers the corporate and employment law interfaces, including transactions and regulatory matters.

Other key lawyers:

Franz-Josef Dahm; Roland Flasbarth; Corinna Schmidt-Murra; Stefan Bäune; Regine Cramer

Key clients


Alfried Krupp Krankenhaus

Bundesverband der Knappschaftsärzte e.V.

Dr. August Wolff GmbH & Co. KG

Fresenius Medical Care

IMEX Dental Gruppe

Klinikum Dortmund gGmbH

KlinikumStadtSoest gGmbH

Lohmann & Rauscher

Universitätsklinikum Essen

Universitätsklinikum Jena

Urban Technology (DrSmile)

Work highlights

Tsambikakis & Partner Rechtsanwälte

Tsambikakis & Partner Rechtsanwälte is experienced in advising hospitals, doctors, pharmaceutical and medical device manufacturers on medical criminal law matters, including investigations and criminal proceedings, as well as compliance matters. The team is jointly led by the commercial, tax and medical criminal law specialist Michael Tsambikakis and the medical law and compliance expert Daniela Etterer. Karolina Kessler, who is also experienced in medical and white-collar criminal law, joined the partner roster in early 2023.

Practice head(s):

Michael Tsambikakis; Daniela Etterer

Other key lawyers:

Karolina Kessler


‘Highly specialized, reliable.’

‘Daniela Etterer: Fast response and practical advice.’

Key clients

Bundesministerium für Gesundheit

Work highlights

  • Advising the management and the supervisory board on the implementation of compliance for the supervisory board in a healthcare group.

  • Corporate representation of a large hospital operator in an investigation into breach of trust and fraud.

  • Support in implementing and operating a whistleblower system in anticipation of the Whistleblower Protection Act for the Federal Ministry of Health.

von BOETTICHER Rechtsanwälte Partnerschaftsgesellschaft mbB

von BOETTICHER Rechtsanwälte Partnerschaftsgesellschaft mbB is experienced in pharmaceutical law with a focus on pharmaceutical advertising law. The team is well versed in the enforcement of claims in interim injunction proceedings pertaining to pharmaceuticals, medical devices and cosmetics. Claudia Böhm regularly represents clients in pharmaceutical advertising law proceedings and is experienced in the vaccines segment. Anselm Brandi-Dohrn is a key contact for contract drafting, including license and cooperation agreements.

Other key lawyers:

Claudia Böhm; Anselm Brandi-Dohrn; Holger Alt

Key clients

Aceto GmbH


Bavarian Nordic GmbH

Belano Medical AG

Betterguards GmbH

CellAct Pharma GmbH

Cellbricks GmbH

EVER Neuro Pharma GmbH (AT); EVER Pharma GmbH (DE); EVER Valinject GmbH (DE)

Gilead Sciences GmbH

LEO Pharma GmbH

Lipotype GmbH

Madaus & Lauscher GmbH

Nekonal S.a.r.l. (Lux)

Sanochemia Pharmazeutika GmbH

Sedana Medical AB (publ)

Work highlights

  • Advising and representing the EVER Group in setting up pharmaceutical production for drugs and medical devices at locations at home and abroad.

  • Advising Gilead Sciences GmbH in competition law disputes with ViiV Healthcare GmbH regarding new scientific data.


WilmerHale's team is led by Hans-Georg Kamann and focuses on regulatory issues pertaining to the pharmaceutical sector and medical devices. Kamann and Peter Gey regularly join forces in contentious proceedings for pharmaceutical and medical device companies as well as associations. Both act from Frankfurt and Brussels and advise at the interfaces with antitrust, competition and EU law. Martin Braun has data protection expertise and advises on product approvals and data transfers as well as clinical studies.

Practice head(s):

Hans-Georg Kamann

Other key lawyers:

Peter Gey; Martin Braun

Key clients

Becton Dickinson GmbH

Bundesverband der Pharmazeutischen Industrie (BPI)

Deutsches Hörgeräte Institut GmbH

Medtronic, Inc

Work highlights

  • Advising Becton Dickinson on, among other things, issues of competition, product liability and distribution law, including advising on disputes relating to advertising for medical devices as well as advising on procurement law issues and contract and antitrust law.

  • Advice and reports on the MDR certification of the Deutsches Hörgeräte Institut GmbH as an independent testing laboratory in accordance with Section 18 MPDG.

  • Successful defense of Medtronic in an IP litigation regarding a new product.